Previous close | 201.54 |
Open | 201.28 |
Bid | 82.61 x 1300 |
Ask | 204.39 x 800 |
Day's range | 200.45 - 204.63 |
52-week range | 185.22 - 254.00 |
Volume | |
Avg. volume | 491,703 |
Market cap | 20.148B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 35.90 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.08 (1.03%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
STERIS (STE) is expected to have witnessed the normalization of the Healthcare backlog, as the company is currently able to ship at a faster pace than the receipt of new orders.
STERIS (NYSE:STE) has had a rough month with its share price down 13%. We, however decided to study the company's...
Edwards Lifesciences, DexCom and STERIS have been highlighted in this Industry Outlook article.